•
Mar 31, 2022

Primerica Q1 2022 Earnings Report

Primerica's first quarter performance was marked by revenue growth in Term Life and Investment and Savings Products, offset by heightened expenses and challenges in the Senior Health segment.

Key Takeaways

Primerica's Q1 2022 results showed an 8% increase in total revenues to $691.2 million, but a 17% decrease in net income to $81.4 million. EPS decreased by 16% to $2.06. The company faced headwinds in the Senior Health segment, while the Term Life and Investment and Savings Products segments showed revenue growth.

Life-licensed sales force decreased 1% year-over-year to 130,206.

Term Life net premiums increased 9%, and adjusted direct premiums increased 10%.

Investment and Savings Products sales increased 7% to $3.1 billion.

Net earnings per diluted share (EPS) decreased 16% to $2.06.

Total Revenue
$691M
Previous year: $638M
+8.4%
EPS
$2.11
Previous year: $2.44
-13.5%
Client Asset Values
$94.2B
Previous year: $85.9B
+9.7%
Life-Licensed Sales Force
130.21K
Previous year: 132.03K
-1.4%
ISP Product Sales
$3.1B
Previous year: $2.85B
+8.8%
Gross Profit
$605M
Previous year: $565M
+7.1%
Cash and Equivalents
$360M
Previous year: $440M
-18.2%
Total Assets
$15.9B
Previous year: $15.1B
+5.4%

Primerica

Primerica

Primerica Revenue by Segment

Forward Guidance

Primerica expects to repurchase a total of $306 million of common stock during 2022.

Revenue & Expenses

Visualization of income flow from segment revenue to net income